Methamphetamine-induced psychosis : clinical features, treatment modalities and outcomes
dc.contributor.author | Thomas, Eileen | en_ZA |
dc.contributor.author | Lategan, Helena | en_ZA |
dc.contributor.author | Verster, Chris | en_ZA |
dc.contributor.author | Kidd, Martin | en_ZA |
dc.contributor.author | Weich, Lize | en_ZA |
dc.date.accessioned | 2017-11-02T08:24:13Z | |
dc.date.available | 2017-11-02T08:24:13Z | |
dc.date.issued | 2016 | |
dc.description | CITATION: Thomas, E., et al. 2016. Methamphetamine-induced psychosis : clinical features, treatment modalities and outcomes. South African Journal of Psychiatry, 22(1):1-6, doi:10.4102/sajpsychiatry.v22i1.980. | |
dc.description | The original publication is available at http://www.sajp.org.za | |
dc.description.abstract | Objective: To investigate the clinical features, prescribing patterns and outcomes of psychiatric inpatients admitted with methamphetamine-induced psychosis. Method: A cross-sectional, descriptive pilot study was conducted between March 2014 and August 2014 at three South African Mental Health Care Act designated hospitals prior to admission to a psychiatric hospital. Patients with methamphetamine-related psychotic symptoms according to the DSM-5 criteria were eligible. Structured face-to-face interviews were conducted and the Brief Psychiatric Rating Scale was employed as a measure of current psychopathology. Results: Fifty-six participants were included. Positive psychotic symptoms (e.g. hallucinations) were more prominent than negative symptoms (e.g. affective blunting). Almost half the participants (43%) had previous episodes of methamphetamine-induced psychosis. Within this group, all had defaulted on the prescribed treatment prior to admission. Only 29% of the participants had received prior formal substance-use rehabilitation as treatment for their disorder. High rates of comorbid cannabis and alcohol use (51%) were recorded. Most of the participants required transfer to specialist psychiatric hospitals. The amounts of methamphetamine used were not a predictor of the persistence of psychosis; however, the pattern of use was. Conclusion: Clinical features correspond with other international findings. The currently employed model of sequential, non-integrated psychiatric and substance use treatment in this setting appears ineffective. | en_ZA |
dc.description.uri | https://www.sajp.org.za/index.php/sajp/article/view/980 | |
dc.description.version | Publisher's version | |
dc.format.extent | 6 pages | |
dc.identifier.citation | Thomas, E., et al. 2016. Methamphetamine-induced psychosis : clinical features, treatment modalities and outcomes. South African Journal of Psychiatry, 22(1):1-6, doi:10.4102/sajpsychiatry.v22i1.980 | |
dc.identifier.citation | 2078-6786 (online) | |
dc.identifier.citation | 1608-9685 (print) | |
dc.identifier.other | doi:10.4102/sajpsychiatry.v22i1.980 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/102434 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | AOSIS Publishing | |
dc.rights.holder | Authors retain copyright | |
dc.subject | Methamphetamine abuse | en_ZA |
dc.subject | Methamphetamine abuse -- Treatment | en_ZA |
dc.subject | Methamphetamine -- Side effects | en_ZA |
dc.subject | Methamphetamine -- Psychological aspects | en_ZA |
dc.title | Methamphetamine-induced psychosis : clinical features, treatment modalities and outcomes | en_ZA |
dc.type | Article | en_ZA |